Redeye leaves its initial take on Xbrane following this mornings news that Xbrane has regained the full rights to BIIB801 following Biogen's termination of the deal.
ANNONS
Redeye leaves its initial take on Xbrane following this mornings news that Xbrane has regained the full rights to BIIB801 following Biogen's termination of the deal.